PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1795299
PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1795299
Optogenetics
Global Optogenetics Market to Reach US$2.1 Billion by 2030
The global market for Optogenetics estimated at US$757.7 Million in the year 2024, is expected to reach US$2.1 Billion by 2030, growing at a CAGR of 18.7% over the analysis period 2024-2030. Type I Optogenetics, one of the segments analyzed in the report, is expected to record a 17.0% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Type II Optogenetics segment is estimated at 21.7% CAGR over the analysis period.
The U.S. Market is Estimated at US$199.2 Million While China is Forecast to Grow at 17.8% CAGR
The Optogenetics market in the U.S. is estimated at US$199.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$327.4 Million by the year 2030 trailing a CAGR of 17.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 17.0% and 16.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.9% CAGR.
Global Optogenetics Market - Key Trends & Drivers Summarized
How Is Optogenetics Transforming Neuroscience and Cellular Research?
Optogenetics is an advanced technique that uses light to control cellular activity in genetically modified cells, particularly neurons. This method allows researchers to manipulate specific cells in real time using light-sensitive proteins, offering unprecedented control over neural circuits and signaling pathways. The approach is revolutionizing neuroscience by enabling detailed mapping of brain activity and understanding of complex neurological behaviors, including those linked to disorders such as Parkinson’s disease, epilepsy, and depression.
Beyond brain research, optogenetics is being explored in cardiology, pain studies, and vision restoration. Its precision and speed make it more effective than pharmacological or electrical stimulation in many contexts. By targeting defined cell populations, optogenetics supports selective activation or inhibition of biological pathways, providing researchers with a tool to probe function at a fine-grained level.
What Technological Innovations Are Expanding the Application Scope?
Recent developments in genetic engineering, viral vector design, and light delivery systems are enhancing the utility of optogenetic methods. New light-sensitive ion channels and opsins are being engineered for activation at different wavelengths and intensities, enabling deeper tissue penetration and reduced thermal damage. These include red-shifted and near-infrared responsive opsins suited for in vivo use.
Miniaturized fiber-optic systems, wireless light delivery devices, and optoelectronic implants are enabling long-term studies in freely moving animal models. Integration with two-photon microscopy, electrophysiology, and functional MRI is supporting multimodal experiments. Advances in CRISPR and viral vector systems are improving gene expression targeting, reducing off-target effects, and expanding applicability beyond the central nervous system.
Where Is Adoption Growing and Which Fields Are Accelerating Research?
Adoption of optogenetics is expanding within academic neuroscience laboratories, pharmaceutical research institutions, and translational medicine programs. North America and Europe lead in research intensity, while Asia-Pacific countries are rapidly increasing investment in neurobiology and bioengineering. Universities and research institutes are applying optogenetics to model psychiatric and neurodegenerative disorders and to explore brain-machine interfaces.
Emerging areas of interest include retinal regeneration, cardiac rhythm modulation, and immune cell signaling studies. Biotechnology firms are investigating optogenetic tools as part of preclinical drug screening, behavioral analysis, and biosensor development. Despite technical complexity, interest in clinical translation is growing, especially for restoring vision and addressing treatment-resistant neurological conditions.
Growth in the Optogenetics market is driven by several factors…
Growth in the optogenetics market is driven by factors such as increasing neuroscience research, rising adoption of precision cell control tools, and continuous innovation in gene delivery and light activation technologies. Demand for advanced neurostimulation methods in academic and translational settings is pushing development of more efficient, customizable optogenetic tools.
The ability to integrate optogenetics with live imaging, behavioral assays, and electrophysiology is enhancing its role in systems biology. Rising investment in neural circuit mapping, psychiatric disorder research, and vision restoration technologies is reinforcing market expansion. Improvements in opsin sensitivity, expression control, and implantable light systems are broadening real-world applicability and sustaining momentum in both research and early clinical domains.
SCOPE OF STUDY:
The report analyzes the Optogenetics market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Optogenetics Type (Type I Optogenetics, Type II Optogenetics)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Select Competitors (Total 41 Featured) -
- Addgene
- Applied Genetic Technologies Corp.
- Bruker Corporation
- Bionic Sight LLC
- Campden Instruments
- Circuit Therapeutics Inc.
- Cobolt Inc.
- Coherent Inc.
- Danaher Corporation
- Elliot Scientific Ltd.
- GenSight Biologics
- GenScript Biotech Corporation
- Hubner Photonics Inc.
- Inscopix
- Jackson Laboratory
- Judges Scientific Plc
- Laserglow Technologies
- Lumentum Holdings Inc.
- Merck KGaA
- Mightex Systems
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
- 1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Tariff Impact on Global Supply Chain Patterns
- Optogenetics - Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
- 2. FOCUS ON SELECT PLAYERS
- 3. MARKET TRENDS & DRIVERS
- Rising Research in Neuroscience and Brain Mapping Spurs Adoption of Optogenetic Tools
- Growing Investment in Precision Medicine Strengthens Business Case for Targeted Neural Modulation
- Advancements in Light-Sensitive Proteins Propel Development of Next-Generation Optogenetic Constructs
- Expansion of Cell-Type Specific Therapies Drives Demand for Genetically Encoded Optical Control Systems
- Integration with CRISPR and Gene Editing Technologies Enhances Functional Versatility of Optogenetics
- Surge in Demand for Non-Invasive Neuromodulation Techniques Throws the Spotlight on Optical Neural Control
- Increasing Focus on Psychiatric and Neurodegenerative Disorders Expands Clinical Use Potential
- Adoption of Fiber Optic Implant Systems Accelerates In Vivo Application of Optogenetics
- Growth in Academic Collaborations and Open-Source Platforms Fuels Innovation and Accessibility
- Emergence of Miniaturized Light Delivery Devices Strengthens Research Applications in Freely Moving Animals
- Rising Use in Cardiac and Vision Research Opens New Avenues Beyond Neuroscience
- 4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Optogenetics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Optogenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 3: World 6-Year Perspective for Optogenetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
- TABLE 4: World Recent Past, Current & Future Analysis for Type I Optogenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 5: World 6-Year Perspective for Type I Optogenetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
- TABLE 6: World Recent Past, Current & Future Analysis for Type II Optogenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 7: World 6-Year Perspective for Type II Optogenetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
III. MARKET ANALYSIS
- UNITED STATES
- Optogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 8: USA Recent Past, Current & Future Analysis for Optogenetics by Optogenetics Type - Type I Optogenetics and Type II Optogenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 9: USA 6-Year Perspective for Optogenetics by Optogenetics Type - Percentage Breakdown of Value Sales for Type I Optogenetics and Type II Optogenetics for the Years 2025 & 2030
- CANADA
- TABLE 10: Canada Recent Past, Current & Future Analysis for Optogenetics by Optogenetics Type - Type I Optogenetics and Type II Optogenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 11: Canada 6-Year Perspective for Optogenetics by Optogenetics Type - Percentage Breakdown of Value Sales for Type I Optogenetics and Type II Optogenetics for the Years 2025 & 2030
- JAPAN
- Optogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 12: Japan Recent Past, Current & Future Analysis for Optogenetics by Optogenetics Type - Type I Optogenetics and Type II Optogenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 13: Japan 6-Year Perspective for Optogenetics by Optogenetics Type - Percentage Breakdown of Value Sales for Type I Optogenetics and Type II Optogenetics for the Years 2025 & 2030
- CHINA
- Optogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 14: China Recent Past, Current & Future Analysis for Optogenetics by Optogenetics Type - Type I Optogenetics and Type II Optogenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 15: China 6-Year Perspective for Optogenetics by Optogenetics Type - Percentage Breakdown of Value Sales for Type I Optogenetics and Type II Optogenetics for the Years 2025 & 2030
- EUROPE
- Optogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 16: Europe Recent Past, Current & Future Analysis for Optogenetics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 17: Europe 6-Year Perspective for Optogenetics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
- TABLE 18: Europe Recent Past, Current & Future Analysis for Optogenetics by Optogenetics Type - Type I Optogenetics and Type II Optogenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 19: Europe 6-Year Perspective for Optogenetics by Optogenetics Type - Percentage Breakdown of Value Sales for Type I Optogenetics and Type II Optogenetics for the Years 2025 & 2030
- FRANCE
- Optogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 20: France Recent Past, Current & Future Analysis for Optogenetics by Optogenetics Type - Type I Optogenetics and Type II Optogenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 21: France 6-Year Perspective for Optogenetics by Optogenetics Type - Percentage Breakdown of Value Sales for Type I Optogenetics and Type II Optogenetics for the Years 2025 & 2030
- GERMANY
- Optogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 22: Germany Recent Past, Current & Future Analysis for Optogenetics by Optogenetics Type - Type I Optogenetics and Type II Optogenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 23: Germany 6-Year Perspective for Optogenetics by Optogenetics Type - Percentage Breakdown of Value Sales for Type I Optogenetics and Type II Optogenetics for the Years 2025 & 2030
- ITALY
- TABLE 24: Italy Recent Past, Current & Future Analysis for Optogenetics by Optogenetics Type - Type I Optogenetics and Type II Optogenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 25: Italy 6-Year Perspective for Optogenetics by Optogenetics Type - Percentage Breakdown of Value Sales for Type I Optogenetics and Type II Optogenetics for the Years 2025 & 2030
- UNITED KINGDOM
- Optogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 26: UK Recent Past, Current & Future Analysis for Optogenetics by Optogenetics Type - Type I Optogenetics and Type II Optogenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 27: UK 6-Year Perspective for Optogenetics by Optogenetics Type - Percentage Breakdown of Value Sales for Type I Optogenetics and Type II Optogenetics for the Years 2025 & 2030
- REST OF EUROPE
- TABLE 28: Rest of Europe Recent Past, Current & Future Analysis for Optogenetics by Optogenetics Type - Type I Optogenetics and Type II Optogenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 29: Rest of Europe 6-Year Perspective for Optogenetics by Optogenetics Type - Percentage Breakdown of Value Sales for Type I Optogenetics and Type II Optogenetics for the Years 2025 & 2030
- ASIA-PACIFIC
- Optogenetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 30: Asia-Pacific Recent Past, Current & Future Analysis for Optogenetics by Optogenetics Type - Type I Optogenetics and Type II Optogenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 31: Asia-Pacific 6-Year Perspective for Optogenetics by Optogenetics Type - Percentage Breakdown of Value Sales for Type I Optogenetics and Type II Optogenetics for the Years 2025 & 2030
- REST OF WORLD
- TABLE 32: Rest of World Recent Past, Current & Future Analysis for Optogenetics by Optogenetics Type - Type I Optogenetics and Type II Optogenetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 33: Rest of World 6-Year Perspective for Optogenetics by Optogenetics Type - Percentage Breakdown of Value Sales for Type I Optogenetics and Type II Optogenetics for the Years 2025 & 2030
IV. COMPETITION
